BOSTON, MA, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- EyeCool Therapeutics, a clinical-stage ophthalmic ...

Looking for WordPress alternatives that fit your stack? Compare builders, ecommerce platforms, headless CMS, and site ...

Explore the groundbreaking AI genomics platform, Inference, launched by Variant Bio to enhance drug discovery using genetic ...

The traditional text-based reviews and faceless star ratings are no longer sufficient to build trust in the high-stakes ...

SiteZeus took a major step forward by expanding into generative AI designed specifically for site selection. With the launch of Zeus.ai, the company introduced a new way for teams to interact with ...

AI is the lever in healthcare marketing priorities as CMOs at Kaiser Permanente and CommonSpirit focus on digital and ...

Organizations have a wealth of unstructured data that most AI models can’t yet read. Preparing and contextualizing this data ...

LAS VEGAS, Jan. 7. 2026 – Caterpillar Inc. (NYSE: CAT) today unveiled a set of AI-powered and autonomous innovations that mark a major step forward for heavy industry, transforming machines into ...

LucidQuest is a strategy and insights agency helping biopharma and healthtech leaders and investors make faster, more informed decisions. Combining deep industry expertise with evidence-based insights ...

Generative AI is accelerating password attacks against Active Directory, making credential abuse faster and more effective.

Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug dis ...